Private
Election interference has sounded many alarms this year, all the way to the White House and the halls of Congress. Now, the Rand Corporation is warning that a coordinated effort on Twitter to influence and provoke chaos during the upcoming presidential election is underway.
“Social media has... Read More »
Under a new partnership, the Biomedical Advanced Research and Development Authority (BARDA) will collaborate with Current Health to develop an algorithm based on a Food and Drug Administration (FDA) approved wearable monitor to predict the need for COVID-19 hospitalization.
By forecasting the... Read More »
Emergent BioSolutions Inc. is one of four companies collaborating to provide hyperimmune globulin products for a new federal clinical trial that will test the safety, tolerability and efficacy of a combination treatment regimen for COVID-19.
The regimen consists of the antiviral remdesivir plus... Read More »
U.S. Space Force personnel said the agency’s Boeing-developed Wideband Global SATCOM (WGS)-11+ communications satellite successfully completed its first major engineering design review.
“Completing this engineering design review is a key milestone and brings us one step closer to delivering... Read More »
A new test being developed by molecular diagnostics company Cepheid gained support from federal agencies this week, on the promise that it could become a one-stop-shop for diagnosing COVID-19, influenza, and RSV.
Support is coming from the Biomedical Advanced Research and Development Authority... Read More »
Biological materials management and standards organization ATCC has secured a potential 10-year, Indefinite Delivery/Indefinite Quantity (IDIQ) contract award from the Biomedical Advanced Research and Development Authority (BARDA).
The agreement, which possesses a ceiling value of $250 million,... Read More »
Over the course of three years, the Biomedical Advanced Research and Development Authority (BARDA) will pay approximately $22 million to Vaxxas to fund phase 1 clinical trials in the U.S. and Australia for a high-density microarray patch capable of administering vaccines needle-free.
This comes... Read More »
A joint effort between the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) brought $98.35 million to COVID-19 testing efforts this week, as part of six contracts awarded under the Rapid Acceleration of Diagnostics (RADx) initiative.
The... Read More »
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) -- a global non-profit dedicated to antibacterial research – is awarding up to $2.5 million to GangaGen Biotechnologies to develop novel antibacterial proteins.
GangaGen, based in Bangalore, India, will develop... Read More »
The professional services firm KBR, Inc. has completed the acquisition of independent provider of space, directed energy, and advanced technology solutions Centauri, LLC from Arlington Capital Partners.
The acquisition expands KBR's military space and intelligence business, as well as the... Read More »
National Institute of Standards and Technology (NIST) researchers maintain they have developed a means of increasing primary SARS-CoV-2 virus testing sensitivity to help identify those who are asymptomatic.
Findings published in Analytical and Bioanalytical Chemistry outlined a mathematical... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has partnered with Mapp Biopharmaceutical, Inc. to develop a new monoclonal antibody therapeutic for all seven major types of Botulinum Neurotoxin.
Botulinum is an incredibly lethal substance responsible for botulism, though it... Read More »
Department of Homeland Security (DHS) said personnel within the agency’s Targeted Violence and Terrorism Prevention program (TVTP) recently hosted its fifth Digital Forum on Terrorism Prevention.
The initiative primarily involved Atlanta-based civil society leaders, providing an opportunity... Read More »
Following three successful clinical trials, Veklury (remdesivir) is now available for hospital purchase directly from its distributor, Gilead Sciences, ending the government’s distribution role.
The move follows five months during which the U.S. government managed allocation and distribution... Read More »
With an initial five laboratories, the Coalition of Epidemic Preparedness Innovations (CEPI) has launched a network of labs worldwide, collectively focused on helping COVID-19 vaccine developers uniformly evaluate and identify successful candidates.
By centralizing, the hope is to assess and... Read More »
As part of a community-focused move, particularly among schools, the United States Department of Health and Human Services (HHS) and The Rockefeller Foundation have agreed to identify and share effective approaches for using rapid point-of-care antigen tests to screen for COVID-19.
The pilot... Read More »
Sandia National Laboratories personnel are espousing the benefits of its Sandia Programs Engineering and Assembly Research (SPEAR) facility, which officials said would expand weapons modernization testing capacity.
Lisa E. Gordon-Hagerty, administrator of the National Nuclear Security... Read More »
A pair of investigational drugs targeting antibiotic-resistant infections will receive nearly $20 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to support phase two and three clinical trials and other efforts to reach U.S. Food and Drug... Read More »
The United Nations reported a major milestone this week for the global Access to COVID-19 Tools (ACT) Accelerator initiative, collecting nearly $1 billion in new financing to guarantee tests, treatment and vaccines for COVID-19.
The ACT Accelerator is a joint effort by the World Health... Read More »
The Denver Health and Hospital Authority signed a $3 million cooperative agreement with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to demonstrate the effectiveness of a Regional Disaster Health Response System... Read More »
A phase one trial of a COVID-19 vaccine jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, Inc. brought positive results, triggering strong immune responses among older volunteers while proving well-tolerated.
According to a report published this... Read More »
BARDA is partnering with Inversa to develop a treatment for eye problems associated with DNA damage, particularly those caused by chemical agents like sulfur mustard gas.
Ingrained in the public mind since its widespread use in WWI, sulfur mustard is a means of chemical warfare that causes the... Read More »
A new report from the Nuclear Threat Initiative (NTI) says some gaps need to be addressed in the international system to prevent and respond to biological events.
NTI is calling on national and global leaders to take action now to prevent future biological events that could match or exceed the... Read More »
Cecil County, Maryland officials said first responders there are recipients of a new, purpose-built FirstNet cell site - providing a boost in wireless communications.
"This is great news for Earleville, Cecil County, and the surrounding areas,” Maryland State Sen. Steve Hershey (R-Dist. 36)... Read More »
Kynamics of Mountain View, Calif., has secured a Department of Homeland Security (DHS) Science and Technology Directorate’s (S&T) Silicon Valley Innovation Program (SVIP) language translation capabilities funding award.
The $192,520 in Phase 1 funding would yield a portable, standalone... Read More »
The ongoing COVID-19 pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats, requiring that decision makers consider improved policies, programs, and technologies to ramp up the federal defense, experts said during the Sept. 24 virtual... Read More »
The Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program awarded $1 million to InferLink Corp. to develop a tool for sharing cybersecurity information.
Inferlink, based in El Segundo, Calif., awarded the Phase II contract to InferLink based on the successful... Read More »
In an effort to better track COVID-19 infections, the Luminex Corporation and the Biomedical Advanced Research and Development Authority (BARDA) have partnered on the creation of a more advanced serology test.
This latest effort is based on the xMAP SARS-CoV-2 Multi-Antigen IgG assay, a... Read More »
A new, phase three clinical trial for Janssen Pharmaceutical Companies’ investigational COVID-19 vaccine began recruiting adult volunteers this week to see if a single dose could prevent symptomatic cases.
The trial will enroll up to 60,000 volunteers at nearly 215 clinical research sites in... Read More »
As part of a 250-325 household study spanning three countries, The Saban Research Institute of Children’s Hospital Los Angeles will participate in a $7.1 million effort to investigate some of the unanswered questions surrounding COVID-19 and influenza transmission.
Among those questions being... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) expanded its partnership with Ortho Clinical Diagnostics to accelerate the development of a COVID-19 antigen test.
The Vitros antigen test is designed for the rapid detection of the virus that causes COVID-19. It is intended for... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has joined University of Pennsylvania researchers from two labs to build lung-on-a-chip technology, which promises a safe means of studying chlorine gas effects and the discovery of treatments.
Chlorine gas was used as a weapon... Read More »
The global initiative known as the COVAX facility announced major news for all seeking relief from the COVID-19 pandemic: a total of 156 economies have banded together under the program, guaranteeing both robust and lower income economies will get vaccines.
This week marked the formal commitment... Read More »
The Nuclear Threat Initiative (NTI) convened a meeting of more than 40 experts worldwide to address the need for better oversight of biotechnology research.
Biotechnology research is essential for reducing pandemic threats and supporting global health. However, scientific advances in the life... Read More »
Department of Homeland Security (DHS) Science and Technology Directorate (S&T) officials said the agency has posted a request for information regarding portable radio repeater products.
The initiative targets emergency responder community indoor and subterranean environments. S&T’s National... Read More »
